Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study Design and Baseline Data of the HPV-PathogenISS Study

Objectives: In women with HIV-associated immunosuppression, HPV infections have an increased risk of progression to high-grade cervical intraepithelial neoplasia (CIN). With the HAART-induced prolonged survival and more protracted clinical course of AIDS, progression of CIN to cervical cancer (CC) has become a clinically relevant issue, and the mechanisms responsible for HIV-HPV interactions need further elucidation. The study design and analysis of the baseline data of our new project are presented.

Material and methods: This project is a combination of a prospective cohort study of HIV- and HIV+ women, and a retrospective analysis of CIN lesions and cervical cancer. Up to the present, 244 women have been enrolled (17 HIV+) and subjected to epidemiological interview, colposcopic examination, sampling for HPV testing and typing (PCR, InnoLiPA), and HPV serology. The retrospective series of biopsies were analysed for 13 biomarkers (monitoring key molecular events) using immunohistochemistry and tested for HPV by PCR and TaqMan.

Results: HIV- and HIV+ women differ in their exposure status to many of the key epidemiological risk factors of cervical cancer, the most significant ones being number of sexual partners (p = 0.0001), age at onset of sexual activity (p = 0.002), and contraception (yes-no) (p = 0.009). The differences in the baseline clinical observations are less dramatic; HIV-positive women had more frequent HSIL PAP tests (p = 0.040), CIN2 or higher in cervical biopsy (p = 0.049), and external genital warts (p = 0.019). The factors predicting intermediate endpoint markers of cervical cancer, i.e., HSIL PAP smear, ATZ2 in colposcopy, and high-grade CIN in biopsy were analysed in univariate and multivariate regression models. All factors significant in univariate analysis were entered in the multivariate model; HIV-status and Pap smear history maintained their independent predictive power of the HSIL Pap test. The most powerful predictor of ATZ2 colposcopy was HSIL in Pap test. Only the HSIL Pap test and ATZ2 colposcopy remained significant independent predictors of high-grade CIN (p = 0.0001 and p = 0.008, respectively) in the multivariate model.

Conclusions: The three intermediate endpoint markers are closely interrelated, but predicted in part by different covariantes in the causal pathway to cervical cancer. To elucidate whether the increased risk of HIV-positive women to high-grade CIN is due a) to their different exposure status to the risk factors, b) to the direct effects of HIV, or c) to molecular interactions between HIV and HPV, we need to complete these analyses separately in HIV+ and HIV- women.

HPV; HIV; Interaction; Risk factors; Pathogenesis; CIN; Colposcopy; Pap smear; Intermediate endpoint markers

[1] IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 64. Papil1omavirusus. IARC, Lyon 1995, 1.

[2] Syrjanen K.J., Syrjanen S.M.: "Papillomavirus Infections in Human Pathology". New York, London, Wiley, 2000, 1.

[3] Franco E., Monsonego J. (eds.). New Developments in Cervical Cancer Screening and Prevention. Oxford, Blackwell Science, 1997, 1.

[4] Burd E.M.: "Human papillomavirus and cervical cancer". C/in. Microbial. Rev., 2003, 16, 1.

[5] Franceschi S., Rajkumar T., Vaccarella S., Gajalakshmi Y., Sharmila A., Snijders P.J. et al.: "Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study" Int. J. Cancer, 2003, 107, 127.

[6] Goncalves M.A., Burattini M.N., Donadi E.A., Massad E.: "Anogenital warts contributing to the risk of squamous intraepithelial lesions among HIV-positive women of Sao Paulo, Brazil" Int. J. Std. AIDS, 2003, 14, 309.

[7] Wright T., Tedd Y., Ellerbrock M.D., Chiasson M.A., Van Devanter N., Xiao-Wei S.: "Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears". Obstet. Gynecol., 1994, 84, 591.

[8] Branca M., Migliore G., Giuliani M. et al.: "Squamous Intraepithelial Lesions (SILs) and HPV associated changes in HIV infected women or at risk of HIV". Eur. J. Gynecol. Oncol., 2000, 21, 155.

[19] Cappiello G., Garbuglia A.R., Salvi R., Rezza G., Branca M. and the DIANAIDS Collaborative Study Group: "HIV infection increases the risk of squamous intraepithelial lesion in women with HPV infection: an analysis of HPV genotypes". Int. J. Cancer, 1997, 72, 982.

[10] Rezza G., Giuliani M., Branca M. et. al.: "Determinants of squamous intraepithelial lesions (SIL) in women with, or at risk for HIV-I infection". Eur. J. Epidemiol., 1997, 13, 937.

[11] Branca M., Garbuglia A.R., Benedetto A., Cappiello T., Leoncini L., Migliore G. et al.: "Factors predicting the persistence of genital human papillomavirus infections and Pap smear abnormality in HIV-positive and HIV-negative women during prospective followup". Int. J. Std. AIDS, 2003, 14, 417.

[12] Carreras R., Fuste P., Castellanos M.E.: "Cervical intra-epithelial neoplasia in HIV-positive women and women with AIDS". Int. J. Gynecol. Obstet., 1997, 58, 325.

[13] Rezza G., Giuliani M., Serraino D., Branca M., Benedetto A., Garbuglia A. et al.: "Risk factors for cervical presence of human papillomavirus DNA among women at risk for HIV infection DIANAIDS Collaborative Study Group". Epidemiol. Infect., 1998, 121, 173.

[14] Amit A., Edwards C.L., Athey P.. Kaplan A.L.: "Extensive subcutaneous metastases from squamous cell carcinoma of the cervix in patient with HIV ". Int. J. Gynecol. Cance,; 2001, 11, 78.

[15] Calore E.E., Pereira S.M., Cavaliere M.J.: "Progression of cervical lesions in HIY-seropositive women: a cytological study" Diagn. Cytopathol., 2001, 24, 117.

[16] Moodley M., Moodley J., Kleinschmidt I.: "Invasive cervical cancer and human immunodeficiency virus (HIV ) infection: a South African perspective". Int. J. Gyneco/. Cancer, 2001, 11, 194.

[17] Delmas M.C., Larsen C., van Benthem B., Hamers F.F., Bergeron C., Poveda J.D. et al.: "Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women". AIDS, 2000, 14, 1775.

[18] Hawes S.E., Critchlow C.W., Faye Niang M.A., Diouf M.B., Diop A., Toure P. et al.: "Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections". J. Infect. Dis., 2003, 188, 555.

[19] Dorrucci M., Suligoi B., Serraino D., Tirelli U., Rezza G.: "Incidence of invasive cervical cancer in a cohort of HlV-seropositive women before and after the introduction of highly active antiretroviral therapy". J. Acquir. Immune Defic. Syndr., 2001, 26, 377.

[20] Grulich A.E.: "Update: cancer risk in persons with HIV/AIDS in the era of combination antiretroviral therapy". AIDS Read., 2000,10, 341.

[21] Clarke B., Chetty R.: "Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer". Mol. Pathol., 2002, 55, 19.

[22] Stein M.D., Cunningham W.E., Nakazono T., Turner B.J., Andersen R.M., Bozzette S.A. et al.: "Screening for cervical cancer in HIV-infected women receiving care in the United States". J. Acquir. Immune Defic. Syndr., 2001, 27, 463.

[23] Holmes K.K.: "Preventing genital infections with human papillomavirus: lessons learned from the HIV epidemic". J. Clin. Viral., 2000, 19, 91.

[24] Williams A.B.: "Gynecologic care for women with HIV infection". J. Obstet. Gynecol. Neonatal. Nurs., 2003, 32, 87.

[25] Branca M., Rossi E., Alderisio M., Migliore G., Morosini P.L., Vecchione A. et al.: "Performance of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative women". Cytopathol., 2001, 12, 84.

[26] Branca M., Migliore G., Giuliani M., Morosini P.L., Mudu P., Cappiello G. et al.: "Using the number of koilocytes to predict HIV serostatus in women with HPY-associated SIL". Acta Cytol., 2000, 44, 1000.

[27] Del Mistro A., Chieco B.L.: "HPV-related neoplasias in HIVinfected individuals". Eur. J. Cancer, 2001, 37, 1227.

[28] Faro S.: "Human papillomavirus typing in HIV-positive women" Infect. Dis. Obstet. Gynecol., 2001, 9, 123.

[29] Hameed M., Fernandes H., Skurnick J., Moore D., Kloser P., Heller D.: "Human papillomavirus typing in HIV-positive women". Infect. Dis. Obstet. Gynecol., 2001, 9, 89.

[30] Goldie S.J., Freedberg K.A., Weinstein M.C., Wright T.C., Kuntz K.M.: "Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus". Am. J. Med., 2001, 111, 140.

[31] Stein M.D., Cunningham W.E., Nakazono T., Turner BJ., Andersen R.M., Bozzette S.A. et al.: "Screening for cervical cancer in HIV-infected women receiving care in the United States". J. Acquir. Immune Defic. Syndr., 2001, 27, 463.

[32] Torrisi A., Del Mistro A., Onnis G.L., Merlin F., Bertorelle R., Minucci D.: "Colposcopy, cytology and HPV-DNA testing in HIVpositive and HIV-negative women". Eur. J. Gynaecol. Oneal., 2000, 21, 168.

[33] Womack S.D., Chirenje Z.M., Gaffikin L., Blumenthal P.O., McGrath J.A., Chipato T. et al.: "HPV-based cervical cancer screening in a population at high risk for HIV infection". Int. J. Cancer, 2000, 85, 206.

[34] Buonaguro F.M., Tornesello M.L., Buonaguro L., Del Gaudio E., Beth-Giraldo E., Giraldo G.: "Role of HIV as cofactor in HPV oncogenesis: in vitro evidences of virus interactions". Antibiot. Chemother., 1994, 46, 102.

[35] Arany I., Tyring S.K.: "Systemic immunosuppression by HIV infection influences HPV transcription and thus local immune responses in condyloma acuminatum". Int. J. Std. AIDS, 1998, 9, 268.

[36] Arany I., Evans T., Tyring S.K.:'Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositivc individuals". Sex Transm. Infect., 1998, 74, 349.

[37] Smith M.K., Goral M.A., Wright J.H., Matrisian L.M., Morris R.J., Kleinszanto A.J.P., Gilmour S.K.: " Ornithine decarboxylase overexpression leads to increased epithelial tumor invasiveness". Cancer Res., 1997, 57, 2104.

[38J Lee D., Hwang S.G., Kim J., Choe J.: " Functional interaction between p/CAF and human papillomavirus E2 protein". J. Biol. Chem., 2001, 275, 7045.

[39] Branca M., Giorgi C., Benedetto A., Favalli C., Ciotti M., Piccione E. et al.: "Assessment of the risk factors, pathogenetic mechanisms and prognosis of HPV infections and cervical cancer in HIV-positive and HIV-negative women with implications in screening and management (HPV-Pathogen!SS Study)". 5th International Multidisciplinary Congress EUROGIN 2003. Paris, April 13-16, 2003.

[40] Smith J.H.: "Bethesda 2001". Cytopathology, 2002, 13, 4.

[41] Stafl A., Wilbanks G.D.: "An international terminology of colposcopy: report of the Nomenclature Committee of the lnternational Federation of Cervical Pathology and Colposcopy". Obstet. Gynecol., 1991, 77, 313.

[42] Costa S., De Nuzzo M., Bonavita B., Infante F.E., Marinelli M., Rambelli V., Rubino A.: "Cervical Loop Excision: Colposcopy limits in pre-surgical assessment of CIN Lesions". Tumori, 2001, 87, 13.

[43] Bauer H.M., Greer C.E., Manos M.: " Determination of genital human Papillomavirus infection using consensus PCR". In: C.SHerrington and J.0.D. McGee (eds.), Diagnostic Molecular Pathology: A Practical Approach. Oxford, Oxford University Press, 1992, 132.

[441 Fujinaga Y., Shimada M., Okazawa K., Fnkushima M., Kato I., Fujinaga K.: "Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction". J. Gen Viral., 1991, 72, 1039.

[45] Kurvinen K., Syrjiinen K., Syrjanen S.: " p53 and bcl-2 protems as prognostic markers in Human papillomavirus-associated cervical lesions". J. Clin. Oneal., 1996, 14, 2120.

[46] Palefsky J.M.: "Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy". Curr. Opin. Oneal., 2003, 15, 382.